BR112012032332A2 - composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo - Google Patents

composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo

Info

Publication number
BR112012032332A2
BR112012032332A2 BR112012032332A BR112012032332A BR112012032332A2 BR 112012032332 A2 BR112012032332 A2 BR 112012032332A2 BR 112012032332 A BR112012032332 A BR 112012032332A BR 112012032332 A BR112012032332 A BR 112012032332A BR 112012032332 A2 BR112012032332 A2 BR 112012032332A2
Authority
BR
Brazil
Prior art keywords
compound
combination
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR112012032332A
Other languages
English (en)
Inventor
Gabriele Amari
Mauro Riccaboni
Stefano Bossolo
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of BR112012032332A2 publication Critical patent/BR112012032332A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112012032332A 2010-06-22 2011-06-17 composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo BR112012032332A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10166907 2010-06-22
PCT/EP2011/060131 WO2011161018A1 (en) 2010-06-22 2011-06-17 Alkaloid aminoester derivatives and medicinal compositions thereof

Publications (1)

Publication Number Publication Date
BR112012032332A2 true BR112012032332A2 (pt) 2016-11-08

Family

ID=43304024

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012032332A BR112012032332A2 (pt) 2010-06-22 2011-06-17 composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo

Country Status (11)

Country Link
US (1) US8492548B2 (pt)
EP (1) EP2585459B1 (pt)
KR (1) KR20130087405A (pt)
CN (1) CN102947300B (pt)
AR (1) AR081964A1 (pt)
BR (1) BR112012032332A2 (pt)
CA (1) CA2803459A1 (pt)
HK (1) HK1182093A1 (pt)
RU (1) RU2580835C2 (pt)
TW (1) TW201204411A (pt)
WO (1) WO2011161018A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
CN102947298B (zh) * 2010-06-22 2016-03-02 奇斯药制品公司 生物碱氨基酯衍生物及其药物组合物
WO2012069275A1 (en) 2010-11-26 2012-05-31 Chiesi Farmaceutici S.P.A. Glycine derivatives and their use as muscarinic receptor antagonists
CA2862008A1 (en) * 2011-12-30 2013-07-04 Chiesi Farmaceutici S.P.A. Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
WO2016042313A1 (en) 2014-09-15 2016-03-24 Verona Pharma Plc Liquid inhalation formulation comprising rpl554

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100869722B1 (ko) 2000-12-22 2008-11-21 알미랄 에이쥐 퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
EP1461336B1 (en) * 2001-12-20 2013-05-22 CHIESI FARMACEUTICI S.p.A. 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
EP1882691A1 (en) 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Quinuclidine derivatives as M3 antagonists
EP2154136A1 (en) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Quinuclidine carbonate derivatives and medicinal compositions thereof
EP2206712A1 (en) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. "Alkaloid aminoester derivatives and medicinal composition thereof"
CN102947298B (zh) * 2010-06-22 2016-03-02 奇斯药制品公司 生物碱氨基酯衍生物及其药物组合物
MA34326B1 (fr) * 2010-06-22 2013-06-01 Chiesi Farma Spa Formulation de poudre sèche comprenant un médicament antimuscarinique

Also Published As

Publication number Publication date
CN102947300A (zh) 2013-02-27
TW201204411A (en) 2012-02-01
HK1182093A1 (zh) 2013-11-22
AR081964A1 (es) 2012-10-31
KR20130087405A (ko) 2013-08-06
CA2803459A1 (en) 2011-12-29
EP2585459A1 (en) 2013-05-01
US8492548B2 (en) 2013-07-23
CN102947300B (zh) 2016-09-21
US20110311458A1 (en) 2011-12-22
RU2012155716A (ru) 2014-06-27
EP2585459B1 (en) 2015-01-07
WO2011161018A1 (en) 2011-12-29
RU2580835C2 (ru) 2016-04-10

Similar Documents

Publication Publication Date Title
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014001255A2 (pt) composto, uso de um composto, combinação, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BR112013030302A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
BR112014013760A2 (pt) composto, composição farmacêutica e uso de um composto
BR112015000420A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014029530A2 (pt) compostos, composição farmacêutica e uso de um composto
BR112014029115A2 (pt) composto, composição farmacêutica, e, uso de um composto ou composição
BR112014005669A2 (pt) composto, composição farmacêutica e uso de um composto
BR112014003567A2 (pt) composto, uso de um composto, e, composição farmacêutica
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
BR112014009471A2 (pt) compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BR112014013177A2 (pt) composto, composição farmacêutica e uso de um composto
BR112014029642A2 (pt) composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112014013178A2 (pt) composto, composição farmacêutica e uso de um composto

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]